Health Catalyst Inc
Last updated September 27, 2026
Organization details
- Legal name
- Health Catalyst Inc
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- HCAT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001636422
Board of directors
-
Anita Pramoda · DirectorSince 2023
-
Benjamin Albert · Director · CEOSince 2026
-
Daniel D. Burton · Director · Chief Executive OfficerSince 2023
-
Duncan Gallagher · DirectorSince 2023
-
Green Jill Hoggard · DirectorSince 2024
-
John A. Kane · DirectorSince 2023
-
Julie Larson-Green · DirectorSince 2023
-
Justin Spencer · DirectorSince 2025
-
Mark B. Templeton · DirectorSince 2023
-
Mathew Paul Arens · DirectorSince 2025
-
Matthew Kolb · DirectorSince 2023
-
S. Dawn Smith · DirectorSince 2023
-
Simeon Kohl · Director · Chief Executive OfficerSince 2026
-
Steven H. Nelson · DirectorSince 2026
Chief executives
Simeon Kohl
· Chief Executive Officer
Since September 2026
Daniel D. Burton
· Chief Executive Officer
Until September 2026
· Former
Benjamin Albert
· CEO
Until September 2026
· Former
Director election results
Annual meeting of July 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.5%
-
97.8%
Board connections
2 of this board's directors also sit on 3 other boards.
- via Mark B. Templeton
- via S. Dawn Smith
- via Mark B. Templeton
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $105,439
- 1 purchase by 1 insider
- Sold, last 12 months
- $200,554
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Simeon Kohl Director, Officer (Chief Executive Officer) | Grant or award | +2,747,385 | — | — |
| Sep 14, 2026 | Simeon Kohl Director, Officer (Chief Executive Officer) | Open-market purchase | +59,000 | $1.79 | $105,439 |
| Sep 10, 2026 | Benjamin Albert Director, Officer (CEO) | Shares withheld for tax | −35,244 | $1.67 | $59,023 |
| Sep 1, 2026 | Benjamin Albert Director, Officer (CEO) | Shares withheld for tax | −321 | $1.70 | $547 |
| Sep 1, 2026 | Alger Jason Officer (Chief Financial Officer) | Shares withheld for tax | −17,973 | $1.70 | $30,619 |
| Sep 1, 2026 | Julie Larson-Green Director | Grant or award | +9,766 | — | — |
| Sep 1, 2026 | Landry Benjamin Officer (General Counsel) | Shares withheld for tax | −13,167 | $1.70 | $22,431 |
| Jul 16, 2026 | Steven H. Nelson Director | Grant or award | +80,691 | — | — |
| Jul 16, 2026 | Justin Spencer Director | Grant or award | +80,691 | — | — |
| Jul 16, 2026 | Julie Larson-Green Director | Grant or award | +80,691 | — | — |
| Jul 16, 2026 | Green Jill Hoggard Director | Grant or award | +80,691 | — | — |
| Jun 10, 2026 | Benjamin Albert Director, Officer (CEO) | Shares withheld for tax | −34,485 | $1.69 | $58,280 |
| Jun 1, 2026 | Benjamin Albert Director, Officer (CEO) | Shares withheld for tax | −336 | $1.37 | $460 |
| Jun 1, 2026 | Llewelyn Linda Officer (Chief People Officer) | Shares withheld for tax | −8,519 | $1.37 | $11,671 |
| Jun 1, 2026 | Alger Jason Officer (Chief Financial Officer) | Shares withheld for tax | −18,804 | $1.37 | $25,761 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.